Arboiz, Daylinda S.
HRN: 12-21-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2025
METRONIDAZOLE 500MG (TAB)
09/20/2025
09/27/2025
PO
500mg
Q8H
H Pylori Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes